Technical Analysis for DVA - DaVita HealthCare Partners Inc.

Grade Last Price % Change Price Change
D 121.55 0.24% 0.29
DVA closed up 0.24 percent on Friday, September 17, 2021, on 2.87 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical DVA trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 0.24%
Outside Day Range Expansion 0.24%
Below Lower BB Weakness 0.24%
Down 3 Days in a Row Weakness 0.24%
Lower Bollinger Band Touch Weakness 0.24%
Older End-of-Day Signals for DVA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
2x Volume Pace about 20 hours ago
Possible Pocket Pivot about 20 hours ago
Possible NR7 about 22 hours ago
Possible Inside Day about 22 hours ago
1.5x Volume Pace 1 day ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


DaVita HealthCare Partners Inc. Description

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. It primarily operates kidney dialysis centers; and provides acute inpatient dialysis and related lab services primarily in dialysis centers and contracted hospitals. The company offers outpatient, home-based, and hospital inpatient hemodialysis services; ESRD laboratory services; and operates or provides management and administrative services to outpatient dialysis centers that are minority owned by the company or wholly owned by third parties. In addition, the company offers DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; infusion therapy services; disease management services; vascular access services; ESRD clinical research programs; and physician services, as well as manages and operates medical groups and physician networks in California, Nevada, Florida and New Mexico. As of December 31, 2012, it operated or provided administrative services through 1,954 outpatient dialysis centers in 44 states in the United States and the District of Columbia. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.


Sector: Healthcare
Industry: Medical Care
Keywords: S&P 500 Medicine Clinical Medicine Disease Clinical Research Dialysis Membrane Technology Hemodialysis Renal Disease Laboratory Services End Stage Renal Disease Stage Renal Disease Therapy Services Vascular Access Nephrology Renal Dialysis Disease Management Kidney Dialysis Kidney Failure Physician Services Rockwell Medical Disease Management Services Infusion Therapy Lab Services Chronic Kidney Failure Esrd Medical Groups Physician Networks

Is DVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 136.48
52 Week Low 80.85
Average Volume 593,466
200-Day Moving Average 117.66
50-Day Moving Average 126.48
20-Day Moving Average 128.59
10-Day Moving Average 125.71
Average True Range 2.43
ADX 27.62
+DI 12.90
-DI 31.94
Chandelier Exit (Long, 3 ATRs) 126.58
Chandelier Exit (Short, 3 ATRs) 128.10
Upper Bollinger Bands 136.98
Lower Bollinger Band 120.19
Percent B (%b) 0.08
BandWidth 13.05
MACD Line -1.69
MACD Signal Line -0.35
MACD Histogram -1.3441
Fundamentals Value
Market Cap 14.83 Billion
Num Shares 122 Million
EPS 6.68
Price-to-Earnings (P/E) Ratio 18.20
Price-to-Sales 1.20
Price-to-Book 7.81
PEG Ratio 0.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 123.56
Resistance 3 (R3) 123.60 122.97 123.23
Resistance 2 (R2) 122.97 122.46 122.95 123.11
Resistance 1 (R1) 122.26 122.14 122.62 122.22 123.00
Pivot Point 121.63 121.63 121.81 121.61 121.63
Support 1 (S1) 120.92 121.12 121.28 120.88 120.10
Support 2 (S2) 120.29 120.80 120.27 119.99
Support 3 (S3) 119.58 120.29 119.88
Support 4 (S4) 119.54